ASTRAZENECA PLC (AZN)
Clinical trial NCT06417801: enrollment: not set → 170 participants.
Clinical trial NCT06417801: enrollment: not set → 170 participants.
Clinical trial NCT04145622: enrollment: not set → 250 participants.
Clinical trial NCT07075640: enrollment: not set → 24 participants.
Clinical trial NCT07195708 updates: 1. start date: 2026-05-30 → 2026-06-30 2. completion date: 2028-10-31 → 2028-12-31 3. primary completion date: 2028-04-30 → 2028-06-30 4. enrollment: not set → 144 participants
Clinical trial NCT06321510 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-12-31 → 2025-09-19 3. primary completion date: 2026-12-31 → 2025-09-19 4. enrollment: not set → 29 participants
Clinical trial NCT05714085: enrollment: not set → 342 participants.
Clinical trial NCT07133633: enrollment: not set → 315 participants.
Clinical trial NCT07480733: enrollment: not set → 410 participants.
Clinical trial NCT05997277: enrollment: not set → 7 participants.
Clinical trial NCT04480853: enrollment: not set → 30 participants.